Richardson, Cody MD

Dr. Ann O'Shea Scheimann is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include pediatric gastroenterology, nutrition and pediatric liver disease including cholestatic liver disease and fatty liver disease. Dr. Scheimann received her B.S. from the University of Dayton. She earned her M.D. from the University of Cincinnati College of Medicine and her M.B.A. from Johns Hopkins. She completed her internship and residency in pediatric medicine and a fellowship in pediatric gastroenterology at the Baylor College of Medicine. In 2000, she joined the Johns Hopkins faculty in pediatrics, where her research focuses on non-alcoholic fatty liver disease, obesity and Prader-Willi syndrome. Prior to joining Johns Hopkins, Dr. Scheimann was an assistant professor of pediatrics at Baylor College of Medicine. In 2005, she developed Weigh Smart, a comprehensive pediatric weight management program funded by the Johns Hopkins Children’s Center, Mt. Washington Pediatric Hospital, and the University of Maryland. She currently serves as the chair of the Pediatric Nutrition Advisory Committee at Johns Hopkins Children's Center. Dr. Scheimann serves on the editorial boards of Pediatrics and Therapeutics, World Journal of Gastroenterology and World Journal of Hepatology. She has received numerous awards and including a grant from the Mt. Washington Pediatric Foundation to start the Weigh Smart program. She has received research support from Agencies including the National Institutes of Health, Foundation for Prader-willi Research and Prader-willi Syndrome Association. She is a member of several professional organizations, including the American Association for the Advancement of the Study of Liver Disease, Obesity Society and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Dr. Stephen J. Meltzer is a Professor of Medicine and Oncology at Johns Hopkins University, Division of Gastroenterology. He is the Director of GI Early Detection Biomarkers Laboratory and a member of the Johns Hopkins Kimmel Cancer Center. His research interests are Gastrointestinal cancer and precancer biomarker discover, development and validation; genomics, epigenomics and bioinformatics, early detection of cancer, outcomes research in cancer and precancer, risk stratification prediction in cancer and precancer, Barrett's esophagus, inflammatory bowel disease-associated cancer, liver cancer and gastric cancer. After receiving degree in Medicine at the State University of New York Medical School, Dr. Meltzer interned at Tulane University in New Orleans and University of Texas Medical Branch in Galveston, TX. He completed his fellowship training program in the University of Colorado and the Lenox Hill Hospital. He was an Assistant Professor in UCLA, Center for Health Science in 1987. Prior to joining the faculty at Johns Hopkins in 2006, he was Professor of Medicine and Pharmacology, Founder and Head of Aero digestive Cancer/Biomarker Program in School of Medicine, University of Maryland at Baltimore. He is an Associate Editor of Cancer Research and a member of the editorial board of Esophageal. He has published 152 original scientific papers in high-impact scientific journals. He also has 43 chapters, review articles, editorials, or letters to the editor; 1 book; and 139 abstracts to his name. He has given a plethora of invited lectures around the world, all involving his principal field of esophageal and gastrointestinal cancer research. He has been the recipient of numerous prestigious national and international awards, including the Robert and Sally D. Funderburg Award in Gastric Cancer Biology and membership in the American Society for Clinical Investigation.Special Interests: Gastrointestinal cancer and precancer biomarker discover, development and validation; genomics, epigenomics and bioinformatics, early detection of cancer, outcomes research in cancer and precancer, risk stratification prediction in cancer and precancer. Barrett's esophagus, inflammatory bowel disease-associated cancer, liver cancer, gastric cancer